Anti-LTBP1 functional antibody

Anti-LTBP1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LTBP1/LTBP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0327-Ab-1/ GM-Tg-hg-SE0327-Ab-2Anti-Human LTBP1 monoclonal antibodyHuman
GM-Tg-rg-SE0327-Ab-1/ GM-Tg-rg-SE0327-Ab-2Anti-Rat LTBP1 monoclonal antibodyRat
GM-Tg-mg-SE0327-Ab-1/ GM-Tg-mg-SE0327-Ab-2Anti-Mouse LTBP1 monoclonal antibodyMouse
GM-Tg-cynog-SE0327-Ab-1/ GM-Tg-cynog-SE0327-Ab-2Anti-Cynomolgus/ Rhesus macaque LTBP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0327-Ab-1/ GM-Tg-felg-SE0327-Ab-2Anti-Feline LTBP1 monoclonal antibodyFeline
GM-Tg-cang-SE0327-Ab-1/ GM-Tg-cang-SE0327-Ab-2Anti-Canine LTBP1 monoclonal antibodyCanine
GM-Tg-bovg-SE0327-Ab-1/ GM-Tg-bovg-SE0327-Ab-2Anti-Bovine LTBP1 monoclonal antibodyBovine
GM-Tg-equg-SE0327-Ab-1/ GM-Tg-equg-SE0327-Ab-2Anti-Equine LTBP1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0327-Ab-1/ GM-Tg-hg-SE0327-Ab-2; GM-Tg-rg-SE0327-Ab-1/ GM-Tg-rg-SE0327-Ab-2;
GM-Tg-mg-SE0327-Ab-1/ GM-Tg-mg-SE0327-Ab-2; GM-Tg-cynog-SE0327-Ab-1/ GM-Tg-cynog-SE0327-Ab-2;
GM-Tg-felg-SE0327-Ab-1/ GM-Tg-felg-SE0327-Ab-2; GM-Tg-cang-SE0327-Ab-1/ GM-Tg-cang-SE0327-Ab-2;
GM-Tg-bovg-SE0327-Ab-1/ GM-Tg-bovg-SE0327-Ab-2; GM-Tg-equg-SE0327-Ab-1/ GM-Tg-equg-SE0327-Ab-2
Products NameAnti-LTBP1 monoclonal antibody
Formatmab
Target NameLTBP1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LTBP1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0327-Ag-1Recombinant multi-species LTBP1 protein


    Target information

    Target IDGM-SE0327
    Target NameLTBP1
    Gene ID4052,268977,59107,709607,475720,101084534,510559,100070522
    Gene Symbol and Synonyms9430031G15Rik,9830146M04,ARCL2E,b2b1000Clo,Ltbp-1,LTBP1,Ltbp1L,TGF-beta1-BP-1,Tgfb
    Uniprot AccessionQ14766,Q00918
    Uniprot Entry NameLTBP1_HUMAN,LTBP1_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseOvary Cancer, Dent disease, Pregnant state
    Gene EnsemblENSG00000049323
    Target ClassificationN/A

    The target: LTBP1, gene name: LTBP1, also named as . The protein encoded by this gene belongs to the family of latent TGF-beta binding proteins (LTBPs). The secretion and activation of TGF-betas is regulated by their association with latency-associated proteins and with latent TGF-beta binding proteins. The product of this gene targets latent complexes of transforming growth factor beta to the extracellular matrix, where the latent cytokine is subsequently activated by several different mechanisms. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.